Opus Genetics (IRD) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.15% |
| Dec 31, 2025 | 984.51% |
| Sep 30, 2025 | 82.76% |
| Jun 30, 2025 | -181.62% |
| Mar 31, 2025 | 281.76% |
| Dec 31, 2024 | -32.11% |
| Sep 30, 2024 | 16.95% |
| Jun 30, 2024 | -72.22% |
| Mar 31, 2024 | -140.98% |
| Dec 31, 2023 | 243.49% |
| Sep 30, 2023 | 139.94% |
| Jun 30, 2023 | 127.13% |
| Mar 31, 2023 | -112.67% |
| Dec 31, 2022 | 1,007.85% |
| Sep 30, 2022 | -42.73% |
| Jun 30, 2022 | 58.00% |
| Mar 31, 2022 | -331.52% |
| Dec 31, 2021 | 215.12% |
| Sep 30, 2021 | -114.55% |
| Jun 30, 2021 | 335.04% |
| Mar 31, 2021 | -137.01% |
| Dec 31, 2020 | 11,976.52% |
| Sep 30, 2020 | 66.92% |
| Jun 30, 2020 | -40.49% |
| Mar 31, 2020 | -114.96% |
| Dec 31, 2019 | 205.15% |
| Sep 30, 2019 | -47.61% |
| Jun 30, 2019 | 145.29% |
| Mar 31, 2019 | -0.05% |
| Dec 31, 2018 | -421.38% |
| Sep 30, 2018 | 58.26% |
| Jun 30, 2018 | 53.71% |
| Mar 31, 2018 | -486.48% |
| Dec 31, 2017 | 219.25% |
| Sep 30, 2017 | 66.72% |
| Jun 30, 2017 | -55.24% |
| Mar 31, 2017 | -134.28% |
| Dec 31, 2016 | 519.59% |
| Sep 30, 2016 | 119.89% |
| Jun 30, 2016 | -1,078.62% |
| Mar 31, 2016 | 111.74% |
| Dec 31, 2015 | -190.77% |
| Sep 30, 2015 | 426.90% |
| Jun 30, 2015 | -184.01% |
| Mar 31, 2015 | 117.55% |
| Dec 31, 2014 | 77.76% |
| Sep 30, 2014 | -1,075.13% |
| Jun 30, 2014 | -109.21% |
| Mar 31, 2014 | 460.25% |
| Dec 31, 2013 | -21.97% |
| Sep 30, 2013 | 331.13% |
| Jun 30, 2013 | -49.30% |
| Mar 31, 2013 | 27.24% |
| Dec 31, 2012 | -76.62% |
| Sep 30, 2012 | -388.84% |
| Jun 30, 2012 | 121.69% |
| Mar 31, 2012 | 47.54% |
| Dec 31, 2011 | -15.28% |
| Sep 30, 2011 | 33.62% |
| Jun 30, 2011 | -153.66% |
| Mar 31, 2011 | 334.21% |
| Dec 31, 2010 | -75.79% |